Compound News and Research

RSS

Compound derived from fruit and vegetables could be used to improve the effects of an established cancer drug

The drug, mitomycin C (MMC), is a well-known anticancer treatment used mainly against solid tumours in the bladder and lower bowel. It is activated by enzymes naturally found in the human body, but its use is limited by severe side effects at higher doses.

5 Oct 2004

Novel compound that resembles vitamin E halves the size of tumors and the ability of cancer to spread

By studying cancer in mice, researchers at The University of Texas at Austin have gained preliminary evidence that a novel compound that resembles vitamin E halves the size of tumors and the ability of cancer to spread to other body sites.

30 Sep 2004

Lycopene may be able to inhibit the growth of prostate tumours

A study by Dutch and German researchers has provided evidence that lycopene may be able to inhibit the growth of prostate tumours and that its effect may be enhanced if it is combined with vitamin E.

30 Sep 2004

Berkeley searches for AIDS cure in a Samoan indigenous tree

The University of California, Berkeley, has signed an agreement with the Samoan government to isolate from an indigenous tree the gene for a promising anti-AIDS drug and to share any royalties from sale of a gene-derived drug with the people of Samoa.

30 Sep 2004

Pine cones may form a new line of attack against MRSA infection

Pine cones may form a new line of attack against methicillin-resistant Staphylococcus aureus (MRSA) infection, the British Pharmaceutical Conference heard this week.

29 Sep 2004

Brand-conscious customers necessitate robust supply chain management in custom procedure tray markets

End users such as surgeons and operating room (OR) staff are very brand conscious, and the inability of custom procedure tray (CPT) vendors to provide a desired brand may result in loss of business and inability to maintain healthy customer relations.

29 Sep 2004

New hope for patients suffering hormone therapy resitant prostate cancer

New hope was offered today to men with advanced prostate cancer that no longer responds to hormone therapy – a persistent problem in prostate cancer treatment.

27 Sep 2004

Active ingredients of soya may help beat breast cancer

Researchers are investigating whether it is possible to turn the active ingredients of soya into a useful medicine that may help to beat breast cancer, the British Pharmaceutical Conference heard today.

27 Sep 2004

New drug application to market ramelteon for insomnia

Takeda Global Research & Development Center announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) to market ramelteon (TAK-375), its investigational drug for insomnia.

26 Sep 2004

Having an infant in poor health decreases the chances a couple living together 12 to 18 months later

A study of mainly unwed, U.S. urban parents finds that fathers of infants in poor health are less likely to be living with the child's mother following the child's first birthday than fathers of healthy children.

23 Sep 2004

Promising lead in developing anti-viral drugs with the potential to fight HIV and HSV

Dr Norelle Daly, from UQ’s Institute for Molecular Bioscience, is looking at the molecular structure of retrocyclin, a molecule with the ability to protect human cells from HIV infection.

23 Sep 2004

Four or more glasses of red wine per week may reduce risk of prostate cancer by 50 percent

Drinking a glass of red wine a day may cut a man's risk of prostate cancer in half, and the protective effect appears to be strongest against the most aggressive forms of the disease

23 Sep 2004

A naturally occurring chemical that may repel yellow fever mosquitoes can now be made in the laboratory

Gaur acid is a natural skin secretion of the gaur, an Asian wild ox. Preliminary evidence suggests that this chemical discourages the landing and feeding of Aedes aegypti, a common mosquito that carries and transmits the yellow fever virus in some parts of the world.

23 Sep 2004

THC in marijuana may block the spread of forms of cancer causing herpes viruses

The compound in marijuana that produces a high, delta-9 tetrahydrocannbinol or THC, may block the spread of several forms of cancer causing herpes viruses, University of South Florida College of Medicine scientists report.

22 Sep 2004

Experimental drug PKC412 may be the key to treating myeloproliferative disease

Scientists at Dana-Farber Cancer Institute and Brigham and Women's Hospital have prolonged the lives of mice with a rare blood disorder by using an experimental drug that blocks signals promoting runaway growth of blood cells.

21 Sep 2004

Certain cancers might one day be cured without the use of toxic chemotherapy and radiation

The eradication of brain tumors in mice following treatment with a novel drug suggests that certain cancers might one day be cured without the use of toxic chemotherapy and radiation.

20 Sep 2004

Vanilla may become a drug to treat sickle cell disease

In addition to its popular role in flavoring ice cream, fudge and cake frosting, vanilla may have a future use as a medicine. Recent laboratory research has strengthened the possibility that a form of vanilla may become a drug to treat sickle cell disease.

20 Sep 2004

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Isis Pharmaceuticals announced today that Eli Lilly and Company licensed LY2275796, a second-generation antisense anti-cancer drug candidate for clinical development.

20 Sep 2004

Researchers have discovered a possible way to distinguish lethal from localized prostate cancers

If future studies show their test -- measuring the level of activity of a signaling pathway called Hedgehog -- can predict which prostate cancers will spread, the results could revolutionize decision making processes for prostate cancer patients, the researchers say.

13 Sep 2004

Health problems among timber workers exposed to industry chemical PCP are to be investigated

The project, funded by the Ministry of Health, aims to ascertain whether timber workers exposed to the PCPs (pentachlorophenols) are dying earlier, getting cancers more often and suffering more chronic health problems, including fatigue, nausea and neuropsychological dysfunction.

13 Sep 2004

Compound News and Research

Compound derived from fruit and vegetables could be used to improve the effects of an established cancer drug

Novel compound that resembles vitamin E halves the size of tumors and the ability of cancer to spread

Lycopene may be able to inhibit the growth of prostate tumours

Berkeley searches for AIDS cure in a Samoan indigenous tree

Pine cones may form a new line of attack against MRSA infection

Brand-conscious customers necessitate robust supply chain management in custom procedure tray markets

New hope for patients suffering hormone therapy resitant prostate cancer

Active ingredients of soya may help beat breast cancer

New drug application to market ramelteon for insomnia

Having an infant in poor health decreases the chances a couple living together 12 to 18 months later

Promising lead in developing anti-viral drugs with the potential to fight HIV and HSV

Four or more glasses of red wine per week may reduce risk of prostate cancer by 50 percent

A naturally occurring chemical that may repel yellow fever mosquitoes can now be made in the laboratory

THC in marijuana may block the spread of forms of cancer causing herpes viruses

Experimental drug PKC412 may be the key to treating myeloproliferative disease

Certain cancers might one day be cured without the use of toxic chemotherapy and radiation

Vanilla may become a drug to treat sickle cell disease

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Researchers have discovered a possible way to distinguish lethal from localized prostate cancers

Health problems among timber workers exposed to industry chemical PCP are to be investigated

Enhancing confidence in chemical ionization spectrometry data eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News